Alireza Rezvani

5PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersEducational technology and computingPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2026
Can alterations in miR-21, miR-1, and miR-224 expression predict personalized medicine chemotherapy in non-small cell lung cancer?

|Mar 06, 2026
Post-Pandemic Virtual Teaching Self-Efficacy: Insights from Medical Educators at Shiraz University of Medical Sciences, Iran.

Ali Reza Rezvani, Nahid Zarifsanaiey, Parviz Shahmirzalou

|Nov 25, 2025
Peripheral Blood Glucocorticoid Receptor α/β (GRα/GRβ) Ratio Predicts Response to Pemetrexed-Based Chemotherapy in Non-Squamous NSCLC: A Prospective Cohort Study.

Bahareh Forouzani-Haghighi, Alireza Rezvani, Bita Geramizadeh

|Jul 05, 2022
Development, usability and quality evaluation of the resilient mobile application for women with breast cancer.

Rita Rezaee, Sima Asadi, Azita Yazdani

|Jan 12, 2021
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial.

Dena Firouzabadi, Amirreza Dehghanian, Alireza Rezvani

Pageof 1

Frequent Collaborators

1 joint publications

Nahid Zarifsanaiey

1 joint publications

Parviz Shahmirzalou

1 joint publications

Leila Rahmati

1 joint publications

Ali Reza Safarpour